dexloxiglumide has been researched along with 1-anilino-8-naphthalenesulfonate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beglinger, C; Bunea, R; D'Amato, M; Degen, L; Drewe, J; Gräni, K; Oesch, S; Piccoli, F | 1 |
Barrett, TD; Breitenbucher, JG; Freedman, JM; Lagaud, GJ; Shankley, NP; Yan, W | 1 |
1 trial(s) available for dexloxiglumide and 1-anilino-8-naphthalenesulfonate
Article | Year |
---|---|
Effect of CCK-1 receptor blockade on ghrelin and PYY secretion in men.
Topics: Adult; Caprylates; Cholecystokinin; Cross-Over Studies; Double-Blind Method; Enzyme Inhibitors; Fatty Acids; Ghrelin; Humans; Infusions, Intravenous; Lactones; Lipase; Male; Oleic Acid; Olive Oil; Orlistat; Pentanoic Acids; Peptide Hormones; Peptide YY; Plant Oils; Receptors, Cholecystokinin; Time Factors | 2007 |
1 other study(ies) available for dexloxiglumide and 1-anilino-8-naphthalenesulfonate
Article | Year |
---|---|
Role of CCK and potential utility of CCK1 receptor antagonism in the treatment of pancreatitis induced by biliary tract obstruction.
Topics: Acute Disease; Amylases; Animals; Bile Ducts; Cholecystokinin; Disease Models, Animal; Ligation; Lipase; Male; NF-kappa B; Pancreatitis; Pentanoic Acids; Phenylpropionates; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin A; Sincalide | 2008 |